Subjects | Variable | Before intervention | After intervention | *P value |
---|---|---|---|---|
Mean(SD) | Mean(SD) | |||
Total (n = 44) | ||||
BMI (kg/m2) | ||||
Normal | - | 2(4.5) | ||
Overwight | 20(45.5) | 28(63.5) | ≤0.001a | |
obese | 24(54.5) | 14(32) | ||
Waist/Hip | 0.97(0.05) | 0.93(0.05) | ≤0.001b | |
APOA-II/APOA-I | 1.46(0.26) | 1.40(0.17) | 0.12b | |
HDL(ng/ml) | 44.90(7.99) | 42.76(7.81) | ≤0.001*b | |
HDL2(ng/ml) | 15.38(0.29) | 14.25(0.28) | 0.03*b | |
HDL3(ng/ml) | 29.95(0.29) | 28.75(0.28) | 0.11b | |
LCAT activity (470/390) | 0.23(0.07) | 0.24(0.09) | 0.09b | |
TT/TC (n = 22) | ||||
BMI (kg/m2) | ||||
Normal | - | - | ||
Overwight | 10(45.5) | 16(72.7) | 0.032a | |
obese | 12(55.5) | 6(27.3) | ||
Waist/Hip | 0.96(0.04) | 0.93(0.04) | ≤0.001b | |
APOA-II/APOA-I | 1.49(0.11) | 1.31(0.16) | 0.002*b | |
HDL(ng/ml) | 43.63(8.16) | 40.81(6.77) | 0.003*b | |
HDL2(ng/ml) | 16.08(0.3) | 13.84(0.21) | 0.005*b | |
HDL3(ng/ml) | 28.04(0.24) | 28.18(0.24) | 0.87b | |
LCAT activity(470/390) | 0.22(0.07) | 0.24(0.07) | 0.35b | |
CC (n = 22) | ||||
BMI (kg/m2) | ||||
Normal | - | 2(9) | ||
Overwight | 10(45.5) | 12(54.5) | 0.032a | |
obese | 12(55.5) | 8(36.5) | ||
Waist/Hip | 0.97(0.06) | 0.93(0.05) | ≤0.001b | |
APOA-II/APOA-I | 1.44(0.36) | 1.48(0.14) | 0.58b | |
HDL(ng/ml) | 46.18(7.79) | 44.71(8.44) | 0.04*b | |
HDL2(ng/ml) | 14.72(0.29) | 14.68(0.34) | 0.95b | |
HDL3(ng/ml) | 31.99(0.32) | 29.34(0.33) | 0.03*b | |
LCAT activity(470/390) | 0.23(0.08) | 0.25(0.10) | 0.12b |